BPG is committed to discovery and dissemination of knowledge
Featured Articles
10/27/2025 11:15:07 AM | Browse: 3 | Download: 11
Publication Name World Journal of Hepatology
Manuscript ID 109898
Country China
Received
2025-05-26 02:53
Peer-Review Started
2025-05-26 02:53
To Make the First Decision
Return for Revision
2025-05-31 09:50
Revised
2025-06-25 06:50
Second Decision
2025-09-11 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-09-11 07:16
Articles in Press
2025-09-11 07:16
Publication Fee Transferred
2025-06-30 15:18
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-10-15 09:06
Publish the Manuscript Online
2025-10-27 10:57
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Hepatocyte nuclear factors dynamically regulate triglyceride metabolic reprogramming in metabolic dysfunction-associated steatotic liver disease: Mechanisms and implications
Manuscript Source Unsolicited Manuscript
All Author List Su-Qun Li, Jin-Hua Wu, Ying Zhou, Chen-Xi Wang, Li Xie, Si-Ying Liu, Yu-Zhi Su, Wei He, Huan Chen, Wei-Wei Zhong and Yi-Huai He
Funding Agency and Grant Number
Funding Agency Grant Number
Science and Technology Planning Projects of Guizhou Province QKHJC-MS[2025]384
Science and Technology Planning Projects of Zunyi City ZSKHHZ(2023)470
WBE Liver Fibrosis Foundation CFHPC2025028
Chinese Foundation for Hepatitis Prevention and Control Muxin Research Fund of Chronic Hepatitis B MX202404
Beijing Liver and Gallbladder Mutual Aid Public Welfare Foundation Artificial Liver Special Fund iGandanF-1082024-RGG018
Student Innovation and Entrepreneurship Training Program of Zunyi Medical University 2024106610923
Corresponding Author Yi-Huai He, MD, Department of Infectious Diseases, Affiliated Hospital of Zunyi Medical University, No. 201 Dalian Street, Zunyi 563000, Guizhou Province, China. 993565989@qq.com
Key Words Hepatocyte nuclear factors; Metabolic dysfunction-associated steatotic liver disease; Triglyceride metabolic imbalance; Dynamic dysregulation of transcriptional networks; Clinical translation
Core Tip Abnormal hepatic triglyceride deposition is the hallmark of metabolic dysfunction-associated steatotic liver disease. While this process may originate either as a hepatic manifestation of systemic metabolic dysfunction or direct local hepatic lipid metabolic imbalance, the two pathways dynamically interact to drive disease progression. Hepatocyte nuclear factors (HNFs) regulate hepatic triglyceride metabolism via transcriptional networks, and their dysfunction constitutes a key driver of metabolic dysfunction-associated steatotic liver disease pathogenesis. Targeting critical nodes in HNF regulatory networks presents new opportunities for precision therapy. This review systematically analyzes the clinical challenges involved in HNF-targeted therapies and explores potential solutions.
Publish Date 2025-10-27 10:57
Citation <p>Li SQ, Wu JH, Zhou Y, Wang CX, Xie L, Liu SY, Su YZ, He W, Chen H, Zhong WW, He YH. Hepatocyte nuclear factors dynamically regulate triglyceride metabolic reprogramming in metabolic dysfunction-associated steatotic liver disease: Mechanisms and implications. <i>World J Hepatol</i> 2025; 17(10): 109898</p>
URL https://www.wjgnet.com/1948-5182/full/v17/i10/109898.htm
DOI https://dx.doi.org/10.4254/wjh.v17.i10.109898
Full Article (PDF) WJH-17-109898-with-cover.pdf
Manuscript File 109898_Auto_Edited_083615.docx
Answering Reviewers 109898-answering-reviewers.pdf
Audio Core Tip 109898-audio.m4a
Conflict-of-Interest Disclosure Form 109898-conflict-of-interest-statement.pdf
Copyright License Agreement 109898-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate 109898-non-native-speakers.pdf
Peer-review Report 109898-peer-reviews.pdf
Scientific Misconduct Check 109898-scientific-misconduct-check.png
Scientific Editor Work List 109898-scientific-editor-work-list.pdf
CrossCheck Report 109898-crosscheck-report.pdf